Page last updated: 2024-08-21

benzoxazoles and Cells, Neoplasm Circulating

benzoxazoles has been researched along with Cells, Neoplasm Circulating in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banda, K; Carver, BS; Chen, Y; Curley, T; Graham, L; Hsieh, AC; Lotan, TL; Pisano, K; Rathkopf, DE; Scher, HI; Shelkey, G; Torres, A	1

Trials

1 trial(s) available for benzoxazoles and Cells, Neoplasm Circulating

Article	Year
A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer. Investigational new drugs, 2018, Volume: 36, Issue:3 Topics: Aged; Benzoxazoles; Eukaryotic Initiation Factor-4E; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases; Treatment Outcome	2018

Article

Year

A phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.

Investigational new drugs, 2018, Volume: 36, Issue:3

Topics: Aged; Benzoxazoles; Eukaryotic Initiation Factor-4E; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases; Treatment Outcome

2018